Fintel reports that on January 7, 2025, Evercore ISI Group upgraded their outlook for Cardinal Health (NYSE:CAH) from In-Line ...

Cardinal Health (CAH – Research Report) received a Buy rating and price target from Evercore ISI analyst Elizabeth Anderson CFA today. The ...

Canandaigua National Bank & Trust Co. lowered its stake in shares of Cardinal Health, Inc. (NYSE:CAH – Free Report) by 2.8% in the fourth quarter, Holdings Channel reports. The institutional investor ...

Bank of America upgraded shares of Cardinal Health (NYSE:CAH – Free Report) from a neutral rating to a buy rating in a report released on Monday, Marketbeat.com reports. Bank of America currently has ...

The latest trading day saw Cardinal Health (CAH) settling at $119.63, representing a +0.28% change from its previous close.

Fintel reports that on January 6, 2025, B of A Securities upgraded their outlook for Cardinal Health (NYSE:CAH) from Neutral ...

The internet is a treasure trove of fascinating stories, and when it comes to the world of medicine, the tales become even ...

Cardinal Health Inc. CAH is well-poised for growth, given its long-term supply agreements, diversified product portfolio and strong quarterly earnings. However, the possibility of losing a major ...

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest ...

Market Growth: The global decubitus ulcer treatment products market is expected to grow at a 5.5% CAGR, reaching USD 8.5 ...